mRNA-1283
VaccineexperimentalCOVID-19
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
1
Earliest trial started Mar 11, 2021 (NCT04813796)
Timeline
Indications
Studied for
Mechanism of action
- SARS-CoV-2Immunity, active
SARS-CoV-2 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07089706 | Phase 4 | Jul 21, 2025 | Moderna Therapeutics |
| NCT05137236 | Phase 2 | Dec 6, 2021 | Moderna Therapeutics |
| NCT04813796 | Phase 1 | Mar 11, 2021 | Moderna Therapeutics |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Moderna Therapeutics | For profit | 3 | 3 | 3 | 2021 |
1 organizations
Page 1 / 1